<code id='979E17601B'></code><style id='979E17601B'></style>
    • <acronym id='979E17601B'></acronym>
      <center id='979E17601B'><center id='979E17601B'><tfoot id='979E17601B'></tfoot></center><abbr id='979E17601B'><dir id='979E17601B'><tfoot id='979E17601B'></tfoot><noframes id='979E17601B'>

    • <optgroup id='979E17601B'><strike id='979E17601B'><sup id='979E17601B'></sup></strike><code id='979E17601B'></code></optgroup>
        1. <b id='979E17601B'><label id='979E17601B'><select id='979E17601B'><dt id='979E17601B'><span id='979E17601B'></span></dt></select></label></b><u id='979E17601B'></u>
          <i id='979E17601B'><strike id='979E17601B'><tt id='979E17601B'><pre id='979E17601B'></pre></tt></strike></i>

          explore

          explore

          author:entertainment    Page View:18765
          translucent 3D DNA helix with blue and purple background
          Adobe

          Verve Therapeutics said Monday that it had received clearance from the Food and Drug Administration to conduct a clinical trial in the U.S. of its experimental, gene-editing treatment for a common form of heart disease.

          The FDA’s action removes a clinical hold on Verve’s CRISPR-based therapy, called VERVE-101, that was placed on it last November. Verve now intends to recruit participants from U.S. sites into a Phase 1 study that’s been underway since last year in New Zealand and the United Kingdom.

          advertisement

          “We’re thrilled to get this clearance for VERVE-101,” said Verve CEO Sek Kathiresan. “Our study is called HEART-1 and our plan now is to activate U.S. sites.”

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          knowledge

          Anesthesiologist group: stop taking Ozempic before surgery
          Anesthesiologist group: stop taking Ozempic before surgery

          EspeciallyinthefirstweeksoftakingdrugslikeOzempic,foodstayslongerinthestomach—aprobleminsurgeries.Ad

          read more
          Teen said 'homophobic slurs' before O'Shae Sibley killing: Criminal complaint
          Teen said 'homophobic slurs' before O'Shae Sibley killing: Criminal complaint

          3:10O'ShaeSibleyinanundatedportrait.CourtesyKemarJewelThe17-year-oldwhohasbeenchargedintheBrooklynga

          read more
          Cancer drug shortages should be causing more outrage
          Cancer drug shortages should be causing more outrage

          DrugshortagesareagrowingproblemintheU.S.,andashortageoflivesavingcancerdrugsinparticularhasreachedcr

          read more

          Custom gene therapy hints at new path for rare disease treatments

          AdobeWhenTimothyYudevelopedmilasen,acustomdrugforayounggirlnamedMilawithBattendisease,heignitedaspar